日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab

对接受曲美利单抗联合度伐利尤单抗治疗的肝细胞癌患者进行免疫相关性的多组学分析

Myojin, Yuta; Babaei, Sepideh; Trehan, Rajiv; Hoffman, Christoph; Kedei, Noemi; Ruf, Benjamin; Benmebarek, Mohamed-Reda; Bauer, Kylynda C; Huang, Patrick; Ma, Chi; Monge, Cecilia; Xie, Changqing; Hrones, Donna; Duffy, Austin G; Armstrong, Paul; Kocheise, Lorenz; Desmond, Fiona; Buchalter, Jemma; Galligan, Marie; Cantwell, Colin; Ryan, Ronan; McCann, Jeff; Bourke, Michele; Mac Nicholas, Ross; McDermott, Ray; Awosika, Joy; Cam, Maggie; Krebs, Rosanna; Budhu, Anuradha; Revsine, Mahler; Figg, William D; Kleiner, David E; Redd, Bernadette; Wood, Bradford J; Wang, Xin Wei; Korangy, Firouzeh; Claassen, Manfred; Greten, Tim F

Quantifying morphologic variations as an alternate to standard response criteria for unresectable primary liver tumors after checkpoint inhibition therapy

量化形态学变异作为免疫检查点抑制剂治疗后不可切除原发性肝肿瘤标准疗效评价标准的替代方法

Saccenti, Laetitia; Varble, Nicole; Borde, Tabea; Mikhail, Andrew S; Kassin, Michael; Levy, Elliot; Xu, Sheng; Hazen, Lindsey A; Ukeh, Ifechi; Vasco, Cyndi; Duffy, Austin G; Xie, Changqing; Monge, Cecilia; Mabry, Donna; Greten, Tim F; Wood, Bradford J

Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial

紫杉醇纳米粒联合顺铂和卡培他滨与顺铂联合吉西他滨作为复发或转移性鼻咽癌患者一线化疗方案的比较:一项随机3期临床试验

Liu, Guo-Ying; Ye, Yan-Fang; Jiang, Yao-Fei; Chen, Gina Jinna; Xia, Wei-Xiong; Huang, Yi-Sheng; Gao, Tian-Sheng; Liu, Yi-Min; Hou, Ya-Ting; Li, Jian-Fei; Liu, Jia-Hao; Lu, Nian; Chen, Chang-Long; Ke, Liang-Ru; Liang, Hu; Bei, Wei-Xin; Li, Wang-Zhong; Dong, Shu-Hui; Liu, Qin; Xie, Changqing; Yao, He-Rui; Xiang, Yan-Qun

Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial

卡瑞利珠单抗和阿帕替尼联合诱导化疗和同步放化疗治疗N3期鼻咽癌:一项II期临床试验

Liang, Hu; Jiang, Yao-Fei; Liu, Guo-Ying; Wang, Lin; Wang, Jian-Wei; Lu, Nian; Xia, Wei-Xiong; Ke, Liang-Ru; Ye, Yan-Fang; Duan, Jin-Lin; Bei, Wei-Xin; Dong, Shu-Hui; Li, Wang-Zhong; Liu, Li-Ting; Zhao, Chong; Xie, Changqing; Xiang, Yan-Qun

Lineage and ecology define liver tumor evolution in response to treatment

谱系和生态学决定了肝肿瘤对治疗的演变反应。

Revsine, Mahler; Wang, Limin; Forgues, Marshonna; Behrens, Shay; Craig, Amanda J; Liu, Meng; Tran, Bao; Kelly, Michael; Budhu, Anuradha; Monge, Cecilia; Xie, Changqing; Hernandez, Jonathan M; Greten, Tim F; Wang, Xin Wei; Ma, Lichun

VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial

VB-111(ofranergene obadenovec)联合纳武利尤单抗治疗微卫星稳定型结直肠癌肝转移患者:一项单中心、单臂 II 期试验

Coffman-D'Annibale, Kelley; Myojin, Yuta; Monge, Cecilia; Xie, Changqing; Hrones, Donna Mabry; Wood, Bradford J; Levy, Elliot B; Kleiner, David; Figg, William Douglas; Steinberg, Seth M; Redd, Bernadette; Greten, Tim F

Primary liver cancer organoids and their application to research and therapy

原发性肝癌类器官及其在研究和治疗中的应用

Zhu, Xiaobin; Trehan, Rajiv; Xie, Changqing

Mechanisms and markers of malignant transformation of oral submucous fibrosis

口腔黏膜下纤维化恶性转化的机制和标志物

Lin, Fen; Xiao, Ting; Wang, Baisheng; Wang, Liping; Liu, Gui; Wang, Rifu; Xie, Changqing; Tang, Zhangui

Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma

在晚期胆道癌患者中,采用度伐利尤单抗和曲美利木单抗联合免疫检查点抑制剂,并辅以或不辅以射频消融治疗。

Monge, Cecilia; Xie, Changqing; Myojin, Yuta; Coffman-D'Annibale, Kelley L; Hrones, Donna; Brar, Gagandeep; Wang, Sophie; Budhu, Anuradha; Figg, William D; Cam, Maggie; Finney, Richard; Levy, Elliot B; Kleiner, David E; Steinberg, Seth M; Wang, Xin Wei; Redd, Bernadette; Wood, Bradford J; Greten, Tim F

Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocol

肝动脉输注泵(HAIP)疗法联合靶向递送IL-12治疗转移性结直肠癌或肝内胆管癌患者:一项II期临床试验方案

Victory, Jack H; Smith, Emily C; Ryan, Carrie E; Lambdin, Jacob; Sarvestani, Amber Leila; Friedman, Lindsay R; Eade, Alyssa V; Larrain, Carolina; Pu, Tracey; Luberice, Kenneth; Ramamoorthy, Bhavishya; Rainey, Ashley J; Hannah, Cathleen E; Smith, Kathleen M; Mabry, Donna; Xie, Changqing; Davis, Jeremy L; Blakely, Andrew M; Gulley, James L; Schlom, Jeffrey; Monge, Cecilia; Greten, Tim F; Hernandez, Jonathan M